Cerus Revenue 2011-2025 | CERS
Cerus revenue from 2011 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
|
Cerus Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $201 |
| 2023 | $187 |
| 2022 | $188 |
| 2021 | $160 |
| 2020 | $114 |
| 2019 | $94 |
| 2018 | $76 |
| 2017 | $51 |
| 2016 | $39 |
| 2015 | $34 |
| 2014 | $36 |
| 2013 | $40 |
| 2012 | $37 |
| 2011 | $33 |
| 2010 | $23 |
|
Cerus Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-09-30 | $60 |
| 2025-06-30 | $60 |
| 2025-03-31 | $49 |
| 2024-12-31 | $57 |
| 2024-09-30 | $51 |
| 2024-06-30 | $51 |
| 2024-03-31 | $43 |
| 2023-12-31 | $53 |
| 2023-09-30 | $47 |
| 2023-06-30 | $48 |
| 2023-03-31 | $38 |
| 2022-12-31 | $51 |
| 2022-09-30 | $46 |
| 2022-06-30 | $48 |
| 2022-03-31 | $43 |
| 2021-12-31 | $50 |
| 2021-09-30 | $42 |
| 2021-06-30 | $38 |
| 2021-03-31 | $30 |
| 2020-12-31 | $34 |
| 2020-09-30 | $29 |
| 2020-06-30 | $27 |
| 2020-03-31 | $25 |
| 2019-12-31 | $26 |
| 2019-09-30 | $23 |
| 2019-06-30 | $22 |
| 2019-03-31 | $22 |
| 2018-12-31 | $20 |
| 2018-09-30 | $19 |
| 2018-06-30 | $19 |
| 2018-03-31 | $17 |
| 2017-12-31 | $19 |
| 2017-09-30 | $13 |
| 2017-06-30 | $11 |
| 2017-03-31 | $8 |
| 2016-12-31 | $12 |
| 2016-09-30 | $10 |
| 2016-06-30 | $9 |
| 2016-03-31 | $8 |
| 2015-12-31 | $10 |
| 2015-09-30 | $8 |
| 2015-06-30 | $9 |
| 2015-03-31 | $8 |
| 2014-12-31 | $10 |
| 2014-09-30 | $10 |
| 2014-06-30 | $9 |
| 2014-03-31 | $8 |
| 2013-12-31 | $9 |
| 2013-09-30 | $11 |
| 2013-06-30 | $10 |
| 2013-03-31 | $10 |
| 2012-12-31 | $11 |
| 2012-09-30 | $8 |
| 2012-06-30 | $9 |
| 2012-03-31 | $9 |
| 2011-12-31 | $10 |
| 2011-09-30 | $9 |
| 2011-06-30 | $7 |
| 2011-03-31 | $7 |
| 2010-12-31 | $6 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.363B | $0.180B |
| Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $213.099B | 24.56 |
| EssilorLuxottica (ESLOY) | France | $157.340B | 0.00 |
| Boston Scientific (BSX) | United States | $137.422B | 31.42 |
| Stryker (SYK) | United States | $135.301B | 26.86 |
| Medtronic (MDT) | Ireland | $129.189B | 17.90 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.110B | 0.00 |
| Agilent Technologies (A) | United States | $40.674B | 25.71 |
| GE HealthCare Technologies (GEHC) | United States | $38.478B | 18.40 |
| ResMed (RMD) | United States | $36.704B | 25.40 |
| Koninklijke Philips (PHG) | Netherlands | $25.999B | 16.98 |
| Terumo (TRUMY) | Japan | $22.090B | 24.87 |
| Insulet (PODD) | United States | $20.766B | 64.45 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.449B | 11.51 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.190B | 0.00 |
| Baxter (BAX) | United States | $9.387B | 7.58 |
| Sunny Optical Technology (SNPTF) | China | $9.054B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.497B | 30.55 |
| Demant (WILYY) | Denmark | $7.038B | 0.00 |
| Haemonetics (HAE) | United States | $4.080B | 18.16 |
| Lantheus Holdings (LNTH) | United States | $4.033B | 12.29 |
| ICU Medical (ICUI) | United States | $3.644B | 23.13 |
| Envista Holdings (NVST) | United States | $3.634B | 20.85 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.950B | 13.46 |
| AtriCure (ATRC) | United States | $2.047B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.956B | 12.57 |
| LeMaitre Vascular (LMAT) | United States | $1.898B | 38.20 |
| Perrigo (PRGO) | Ireland | $1.861B | 4.66 |
| Curaleaf Holdings (CURLF) | Canada | $1.809B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.616B | 16.14 |
| Neogen (NEOG) | United States | $1.517B | 29.08 |
| AdaptHealth (AHCO) | United States | $1.394B | 20.18 |
| Capricor Therapeutics (CAPR) | United States | $1.311B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.288B | 56.46 |
| Kestra Medical Technologies (KMTS) | United States | $1.262B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.193B | 353.86 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.954B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.927B | 0.00 |
| InMode (INMD) | Israel | $0.917B | 10.36 |
| Omeros (OMER) | United States | $0.797B | 0.00 |
| Valneva SE (VALN) | France | $0.763B | 0.00 |
| CeriBell (CBLL) | United States | $0.749B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.488B | 13.30 |
| BillionToOne (BLLN) | United States | $0.464B | 0.00 |
| Evolus (EOLS) | United States | $0.459B | 0.00 |
| SNDL (SNDL) | Canada | $0.447B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.424B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.362B | 0.00 |
| Quanterix (QTRX) | United States | $0.356B | 0.00 |
| Brainsway (BWAY) | Israel | $0.350B | 59.67 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.312B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.279B | 22.24 |
| Cresco Labs (CRLBF) | United States | $0.271B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.257B | 151.00 |
| Sanuwave Health (SNWV) | United States | $0.256B | 0.00 |
| Organigram Global (OGI) | Canada | $0.225B | 0.00 |
| High Tide (HITI) | Canada | $0.220B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.217B | 0.00 |
| Owens & Minor (OMI) | United States | $0.213B | 2.14 |
| OraSure Technologies (OSUR) | United States | $0.183B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.181B | 15.94 |
| Exagen (XGN) | United States | $0.162B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.161B | 19.82 |
| Apyx Medical (APYX) | United States | $0.154B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.150B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.149B | 0.00 |
| Biote (BTMD) | United States | $0.126B | 5.50 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.115B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.110B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.092B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 13.31 |
| MacroGenics (MGNX) | United States | $0.089B | 0.00 |
| Sharps Technology (STSS) | United States | $0.075B | 0.00 |
| Nephros (NEPH) | United States | $0.054B | 39.38 |
| ImmuCell (ICCC) | United States | $0.053B | 22.58 |
| Cytosorbents (CTSO) | United States | $0.041B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Jin Medical (ZJYL) | China | $0.034B | 0.00 |
| United-Guardian (UG) | United States | $0.028B | 14.00 |
| Zynex (ZYXI) | United States | $0.027B | 0.00 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Modular Medical (MODD) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.017B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.015B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.003B | 0.00 | |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |